[{"id":"a06a1f8c-26c1-4f1d-a722-79204f2c042a","acronym":"RVU120-SOL-021","url":"https://clinicaltrials.gov/study/NCT05052255","created_at":"2022-12-09T16:57:58.006Z","updated_at":"2024-07-02T16:35:19.350Z","phase":"Phase 1/2","brief_title":"RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors","source_id_and_acronym":"NCT05052255 - RVU120-SOL-021","lead_sponsor":"Ryvu Therapeutics SA","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" ER expression","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e romaciclib (RVU120)"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 08/13/2021","start_date":" 08/13/2021","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 05/01/2025","study_completion_date":" 05/01/2025","last_update_posted":"2024-02-14"}]